STAT3 and glioblastoma: [72] also reported that TEFT enhanced sensitivity of GBM xenograft models to sorafenib treatment in nude mice, and sorafenib increased the susceptibility of GBM cells to TEFT‐induced apoptosis through inhibition of STAT3.